Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair

Ali Pedram1, Mahnaz Razandi, Albert J Evinger

  • 1Department of Medicine, University of California, Irvine, Irvine CA 92717, USA.

Insights

Estrogen restrains DNA damage response by blocking ATR kinase activation in ER-positive breast cancer cells. This estrogen action may be relevant to breast cancer development and treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • DNA damage activates the ataxia telangiectasia-mutated and Rad3-related (ATR) kinase signaling cascade.
  • The mechanisms restraining ATR activity, particularly in the context of breast cancer, are not fully understood.

Purpose of the Study:

  • To investigate how estrogen receptor (ER) signaling influences ATR activation in response to DNA damage in ER-positive breast cancer cells.
  • To elucidate the molecular pathways by which estrogen restrains ATR activity and its downstream effects on DNA repair and genomic stability.

Main Methods:

  • Treatment of ER-positive breast cancer cells with DNA-damaging agents (UV, ionizing radiation, hydroxyurea) and 17-beta-estradiol (E(2)).
  • Assessment of ATR kinase activity, phosphorylation of p53 and Chk1, and protein-protein interactions (ATR-TopBP1, Claspin-Chk1).
  • Analysis of cell cycle progression, DNA repair foci (gammaH2AX, Rad51), and chromosomal damage.

Main Results:

  • 17-beta-estradiol (E(2)) substantially blocks ATR activation via plasma membrane-localized ERalpha, reducing ATR-dependent phosphorylation of p53 and Chk1.
  • E(2)/ER reduces ATR-TopBP1 association and inhibits Claspin-Chk1 association through PI3K/AKT signaling, preventing G2/M checkpoint activation.
  • E(2) delays DNA repair, prolongs the resolution of DNA damage markers, and increases chromosomal damage, indicating impaired DNA repair.

Conclusions:

  • Estrogen receptor signaling restrains ATR cascade activation in ER-positive breast cancer cells.
  • This estrogen-mediated restraint of ATR activity impacts DNA repair dynamics and genomic stability.
  • The inhibition of ATR signaling by estrogen may represent a novel mechanism relevant to breast cancer progression and therapeutic strategies.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...